Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories

Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
Acquisition provides Renaissance with world-class semi-solid, liquid, and sterile pharmaceutical contract development and manufacturing capabilities

LAKE FOREST, Ill., Jul 05, 2012 -- Renaissance Acquisition Holdings, LLC ("Renaissance"), a portfolio company of RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has acquired DPT Laboratories, a contract development and manufacturing organization (CDMO).

DPT, the industry leader for semi-solids and liquids, is based in San Antonio, TX, where it has research and development as well as manufacturing facilities. It also is expanding its presence in the sterile and specialty products markets, with facilities in Lakewood, NJ, that specialize in the development and aseptic manufacturing of clinical trial material and commercial scale products to meet sterile requirements.

DPT headquarters and staff will continue to be located in San Antonio and its management team will remain in place, the companies announced. As a result of the transaction, DFB Pharmaceuticals, based in San Antonio and Fort Worth, TX, will maintain a meaningful interest in the combined business and will provide oversight and counsel through representation on the Renaissance Board of Directors.

"As we review investment opportunities, we look for outstanding companies that deliver a value-added proposition, with strong management teams and excellent reputations in the markets in which they compete," said Pierre Frechette, President and CEO of Renaissance Acquisition Holdings. "As a market leader in the contract development and manufacturing space, DPT's experienced management team has established a world-class reputation in semi-solids and liquids, as well as a sterile business with an outstanding regulatory track record that is poised for significant growth. Partnering with DPT to invest in its continued growth and success is a perfect fit with our strategy of building companies for the long term."

"Renaissance and its management team bring a depth of industry experience, including a specific understanding of the contract manufacturing and development space, along with a successful history of partnering with companies like ours to help them grow," said Paul Johnson, Group President and COO of DPT. "This partnership provides the resources we need to accelerate our long-term strategic plans, which include maximizing our semi-solid and liquid business in San Antonio, and achieving aggressive growth in our sterile and specialty products business in Lakewood."

About Renaissance Acquisition Holdings

Renaissance Acquisition Holdings (Renaissance), Lake Forest, IL is a pharmaceutical company formed in partnership with RoundTable Healthcare Partners and Pierre Frechette, the former CEO of Sabex, a previous RoundTable portfolio company. The mission of Renaissance is to invest in small to mid-size pharmaceutical companies that can benefit from its extensive industry relationships and operational expertise.

About DPT Laboratories

DPT is a contract development and manufacturing organization (CDMO) providing companies the best solutions to their sterile and non-sterile drug development and manufacturing needs through innovation, technology and service. Specializing in semi-solid and liquid dosage forms, DPT has a reputation for quality, unmatched technical expertise, extensive manufacturing capabilities and an exemplary regulatory compliance record. With five cGMP facilities, including R&D, manufacturing and packaging operations in San Antonio and Lakewood, N.J., DPT offers full service outsourcing solutions. For more information, call 210-476-8100 or visit .

About RoundTable Healthcare Partners

RoundTable Healthcare Partners, Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise. RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model. RoundTable currently manages $1.9 billion in capital, including three equity funds totaling $1.5 billion and two subordinated debt funds totaling $400 million. More information about RoundTable Healthcare Partners can be found at .

Photos/Multimedia Gallery Available:

SOURCE: DPT Laboratories and Renaissance Acquisition Holdings

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.